[SLRX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 36.99%
YoY- 82.95%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 18 0 0 0 0 -
PBT -1,424 -1,715 -882 -2,443 -3,877 -5,341 -6,371 -63.20%
Tax 0 0 -0 -89 -120 -80 111 -
NP -1,424 -1,715 -882 -2,443 -3,877 -5,261 -6,482 -63.62%
Tax Rate - - - - - - - -
Total Cost 1,424 1,715 900 2,443 3,877 5,261 6,482 -63.62%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -4,928.44 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -2.37 -3.27 -0.22 -0.65 -1.43 -2.20 -2.88 -12.19%
EPS Diluted -2.37 -3.27 -0.22 -0.65 -1.43 -2.20 -2.88 -12.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.